The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
May 3rd 2024
Despite the increased survival rates in all 4 evaluated racial groups, both adult and pediatric non-Hispanic African American patients continued to have worse outcomes.
Experts Report Need for Framework to Address CNS Immune-Related AEs Resulting From ICI Treatment
April 30th 2024According to the speaker, the complexity of immune-related adverse events resulting from immune checkpoint inhibitors requires a lot of collaborative discussion between patients and providers.
Read More
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood Cancer
Advances, challenges, and promising innovations emerge.
Read More
The Fludarabine Shortage and Its Ripple Effects: Navigating the Crisis
The significant surge in oncology drug shortages in 2023 particularly affected essential chemotherapeutic drugs.
Read More
Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.
Read More